Literature DB >> 4373492

The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.

C R McMillin, H Saito, O D Ratnoff, A G Walton.   

Abstract

Hageman factor (factor XII) is activated by exposure to surfaces such as glass or by solutions of certain compounds, notably ellagic acid. Changes in the structure of Hageman factor accompanying activation have been examined in this study by circular dichroism spectroscopy. The spectrum of unactivated Hageman factor in aqueous solutions suggests that its conformation is mainly aperiodic. Various perturbants altered the conformation of Hageman factor in differing ways, demonstrating the sensitivity of Hageman factor to its environment. After activation of Hageman factor with solutions of ellagic acid, a negative trough appeared in the region of the circular dichroism spectrum commonly assigned to tyrosine residues, along with other minor changes in the peptide spectral region. Some of these changes are similar to changes that occurred upon partial neutralization of the basic residues at alkali pH. Activation of Hageman factor by adsorption to quartz surfaces (in an aqueous environment) also produced changes similar to those in the ellagic acid-activated Hageman factor, including the negative ellipticity in the tyrosine region. These observations suggest that the activation process may be related to a change in status of some of the basic amino acid residues, coupled with a specific change in the environment of some tyrosine residues. The importance of these changes during the activation process remains to be determined. The sensitivity of Hageman factor to its environment is consistent with the view that the initiation of clotting by exposure of plasma to appropriate agents is brought about by alterations in the conformation of Hageman factor that occur in the apparent absence of Fletcher factor or other recognized clotting factors.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373492      PMCID: PMC301685          DOI: 10.1172/JCI107877

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Protein denaturation.

Authors:  C Tanford
Journal:  Adv Protein Chem       Date:  1968

2.  Ultraviolet rotatory properties of polypeptides in solution. II. Poly-L-serine.

Authors:  F Quadrifoglio; D W Urry
Journal:  J Am Chem Soc       Date:  1968-05-22       Impact factor: 15.419

3.  The circular dichroism of polypeptide films.

Authors:  L Stevens; R Townend; S N Timasheff; G D Fasman; J Potter
Journal:  Biochemistry       Date:  1968-10       Impact factor: 3.162

4.  New chain conformations of poly(glutamic acid) and polylysine.

Authors:  M L Tiffany; S Krimm
Journal:  Biopolymers       Date:  1968       Impact factor: 2.505

5.  Optical activity and conformation of carbohydrates. II. Opitical rotatory dispersion and circular dichroism studies on immunochemically reactive oligo- and polysaccharides containing amino sugars and their derivatives.

Authors:  E A Kabat; K O Lloyd; S Beychok
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

6.  Hageman factor: alterations in physical properties during activation.

Authors:  V H Donaldson; O D Ratnoff
Journal:  Science       Date:  1965-11-05       Impact factor: 47.728

7.  Hageman factor, a novel sialoglycoprotein with esterase activity.

Authors:  J G Schoenmakers; R Matze; C Haanen; F Zilliken
Journal:  Biochim Biophys Acta       Date:  1965-07-01

8.  Optical rotatory dispersion and circular dichroism of the beta-form of silk fibroin in solution.

Authors:  E Iizuka; J T Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1966-05       Impact factor: 11.205

9.  The optical rotatory dispersion of aromatic amino acids and the side chain-dependent Cotton effects in proteins.

Authors:  A Rosenberg
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

10.  An analysis of the tyrosine circular dichroism bands in ribonuclease.

Authors:  N S Simmons; A N Glazer
Journal:  J Am Chem Soc       Date:  1967-09-13       Impact factor: 15.419

View more
  12 in total

1.  Purification of high molecular weight kininogen and the role of this agent in blood coagulation.

Authors:  H Saito
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

Authors:  S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

5.  Amidolytic properties of single-chain activated Hageman factor.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).

Authors:  J Y Chan; C E Burrowes; H Z Movat
Journal:  Agents Actions       Date:  1978-01

8.  Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.

Authors:  H Saito; S M Hamilton; A S Tavill; L T Goodnough; L Louis; A Angell
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  Guinea pig Hageman factor as a vascular permeability enhancement factor.

Authors:  T Yamamoto; C G Cochrane
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

10.  Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.

Authors:  H Saito; S J Scialla
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.